Tg Therapeutics (TGTX) Net Margin (2017 - 2026)
Tg Therapeutics' (TGTX) quarterly Net Margin came in at 9.64% in Q1 2026, up 545.0% year-on-year from 1.5% in Q1 2025, and down 20.74% quarter-over-quarter from 12.17% in Q4 2025.
Tg Therapeutics (TGTX) Net Margin (2017 - 2026) Analysis & Trends
Tg Therapeutics' Net Margin history runs 10 years deep, the most recent figure standing at 9.64% for Q1 2026.
- On a quarterly basis, Net Margin rose 545.0% year-over-year to 9.64% in Q1 2026; TTM through Mar 2026 was 66.01%, a 5380.0% increase from a year earlier, with the FY2025 full-year figure at 72.62%, up 6306.0% from the prior year.
- Net Margin fell to 9.64% in Q1 2026 per TGTX's latest filing, from 12.17% in the prior quarter.
- Across five years, Net Margin topped out at 241.73% in Q3 2025 and bottomed at 104777.5% in Q4 2022.
- The 5-year median for Net Margin is 4.19% (2025), against an average of 9529.12%.
- Across the five-year window, Net Margin sank 10064622 bps in 2022 and surged 10474719 bps in 2023, its largest moves.
- Year by year, Net Margin stood at 104777.5% in 2022, then surged by 100 bps to 30.31% in 2023, then soared by 196 bps to 29.01% in 2024, then slumped by 58 bps to 12.17% in 2025, then decreased by 21 bps to 9.64% in 2026.
- Per Business Quant, the three latest TGTX Net Margin figures stand at 9.64% (Q1 2026), 12.17% (Q4 2025), and 241.73% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Tg Therapeutics | 8.88 Bn | 8.80 Bn | 171.41 Mn | 9.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.64% |
| Dec 31, 2025 | 12.17% |
| Sep 30, 2025 | 241.73% |
| Jun 30, 2025 | 19.97% |
| Mar 31, 2025 | 4.19% |
| Dec 31, 2024 | 29.01% |
| Sep 30, 2024 | 4.61% |
| Jun 30, 2024 | 9.33% |
| Mar 31, 2024 | -16.87% |
| Dec 31, 2023 | -30.31% |
| Sep 30, 2023 | 68.71% |
| Jun 30, 2023 | -296.19% |
| Mar 31, 2023 | -502.78% |
| Dec 31, 2022 | -104,777.50% |
| Sep 30, 2022 | -43,577.66% |
| Jun 30, 2022 | -9,466.33% |
| Mar 31, 2022 | -3,726.84% |
| Dec 31, 2021 | -4,131.28% |
| Sep 30, 2021 | -5,082.46% |
| Jun 30, 2021 | -5,459.35% |